Apotex To Pay AstraZeneca $98M For Prilosec IP Infringement
A New York federal judge on Tuesday ordered Apotex Corp. to pay $98.5 million to AstraZeneca AB for infringing two patents covering the latter's indigestion drug Prilosec, about three months after...To view the full article, register now.
Already a subscriber? Click here to view full article